Results 111 to 120 of about 125,964 (294)

Issues for countries considering introducing the "fourth hurdle": The case of Hungary [PDF]

, 2004
Objectives: This study outlines the needs and current development of the "fourth hurdle" (i.e., requirement of effectiveness and cost-effectiveness data for drug coverage policy decisions) in Hungary, describes the legal background and seeks to address ...
Boncz, I, Drummond, M, Gulacsi, L
core   +1 more source

Continuing use of e‐cigarettes after stopping smoking and relapse: Secondary analysis of a large randomised controlled trial

Addiction, EarlyView.
Abstract Background and aims Smokers quitting successfully with the help of e‐cigarettes often continue vaping. It is not known whether this promotes or prevents relapse back to smoking. This study aimed to determine whether use of e‐cigarettes after successful smoking cessation affects the probability of relapse later on.
Peter Hajek, Dunja Przulj, Katie Myers Smith, Jinshuo Li, Peter Sasieni, Louise Ross, Hayden McRobbie, Maciej Goniewicz, Francesca Pesola   +8 more
wiley   +1 more source

Radiosynthesis and Preliminary Evaluation of A Styryl Pyridine Derivative 18F-SPy5 as Aβ Imaging Agents

Journal of Isotopes
18F-AV45 was the first β-amyloid (Aβ) imaging drug approved by the U.S. Food and Drug Administration and the first positron emission tomography drug for Alzheimer’s disease (AD) diagnosis in the world.
Zhongyong LI, Huibo GAO, Hailong ZHAO
doaj   +1 more source

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications [PDF]

, 2019
© 2019 Salek, Lussier Hoskyn, Johns, Allen and Sehgal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).This analysis follows our recent study showing that Canadian public reimbursement delays
Adcock, Balasubramanian, Bertozzi, Bruce, Cave, Curtis, Hazell, Jeffcott, Milliken, Millson, Navarria, O’Connor, Pessina, Russo, Salek, von Elm   +15 more
core   +3 more sources

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson   +4 more
wiley   +1 more source

Targeted Systemic Therapies for Atopic Dermatitis in Australia: A Narrative Review

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease estimated to affect approximately 30% of children and 10%–15% of adults in Australia. Of those with this condition, one in five is estimated to have moderate‐to‐severe disease.
Diana Rubel, Peter Foley, Kathryn A. Gibson, Anita Townsend, Gabrielle Louise Reppen, William Romero Gallardo   +5 more
wiley   +1 more source

Who needs what from a national health research system: Lessons from reforms to the English Department of Health's R&D system [PDF]

, 2010
This article has been made available through the Brunel Open Access Publishing Fund.Health research systems consist of diverse groups who have some role in health research, but the boundaries around such a system are not clear-cut.
A Culyer, A Haines, A Haines, A Harrison, A Irwin, A Kennedy, A Kennedy, Academy of Medical Sciences, Academy of Medical Sciences, AD Kennedy, B Soper, B Wilson, Biosciences Innovation and Growth Team, Bryony Soper, C McCourt, C Pope, C Saunders, C Weiss, C Zarcadoolas, D Cooksey, D Wanless, D Wanless, DC Pelz, Department of Health, Department of Health, Department of Health, Department of Health, Department of Health, Department of Health, Department of Health, Department of Health, E West, G McLachan, G Watts, H Nowotny, House of Lords Select Committee on Science and Technology, HTO Davies, I Hargreaves, J Brown, J Darbyshire, J Lavis, J Lexchin, J Lomas, J Lomas, J Lomas, JL Denis, JL Denis, JM Tetroe, JN Lavis, K Stateley, LF Frederiksen, M Buxton, M Buxton, M Buxton, M Gibbons, M Halladay, M Kogan, M Kogan, M Kogan, M Peckham, M Peckham, M Polyani, M Shergold, N Black, N Black, N Fulop, N Mays, N Mays, N Mays, National Institute for Health Research, National Institute for Health Research, National Nursing Research Unit, Nicholas Mays, NIHR Health Technology Assessment Programme, NIHR Service Delivery and Organisation Programme, Office for Strategic Coordination of Health Research (OSCHR), P Dash, PA Diethelm, R Grilli, R Haldane, R Pawson, R Steel, Report Rothschild, S Buckland, S Davies, S Hanney, S Hanney, S Kuruvilla, S Kuruvilla, S Kuruvilla, S Oliver, S Peckham, Service Delivery Organisation (SDO), Shyama Kuruvilla, SPT Hanney, Stephen Hanney, T Milewa, T Pang, UK Clinical Research Collaboration, W Cohen, W Holland   +100 more
core   +6 more sources

HTA283 A Scoping Review of Health Technology Assessment Agency (HTA) and Health Economic (HE) Modelling Guidelines for Identification of Health Economic Model Inputs [PDF]

, 2023
J.B. Lister, Suzy Paisley, Paul Tappenden, Christopher Carroll   +3 more
openalex   +1 more source

Characteristics of Women, Intrapartum Interventions, and Maternal and Neonatal Outcomes Among Users of Intrapartum Water Immersion: The UK POOL Cohort Study

Birth, EarlyView.
ABSTRACT Background The POOL study explored intrapartum water immersion and associated maternal and neonatal outcomes at 26 UK sites 2015–2022. Methods Retrospective and prospective data captured in electronic maternity and neonatal UK National Health Service (NHS) information systems. Analysis—(a) proportions of women using and factors associated with
Julia Sanders, Christy Barlow, Peter Brocklehurst, Rebecca Cannings‐John, Susan Channon, Judith Cutter, Billie Hunter, Mervi Jokinen, Fiona Lugg‐Widger, Sarah Milosevic, Chris Gale, Rebecca Milton, Leah Morantz, Shantini Paranjothy, Rachel Plachcinski, Michael Robling   +15 more
wiley   +1 more source

HTA und komplexe Herausforderungen: HTA in Europa – Visionen und Entwicklungen

, 2017
Workshop der GMDS Arbeitsgruppen Abstract: Der interdisziplinäre Workshop der AGs/AKs HTA, Methodik Systematischer Reviews, Gesundheitsökonomie und Medical Decision Making gibt in diesem Jahr einen Überblick zu den aktuellen Entwicklungen und Herausforderungen im jeweiligen Bereich[zum vollständigen Text gelangen Sie über die oben angegebene URL]
Herrmann, KH, Jensen, K, Siebert, U, Schramm, W, Rüther, A   +4 more
openaire   +2 more sources